BIO President & CEO Jim Greenwood On How Global Financial Crisis Affects Biotech Innovation

  • Recommend
  • Tweet
  • Print
  • Email

How is the global financial crisis and credit crunch affecting the ability of biotech companies to continue their research and development of innovative new products? BIO President & CEO Jim Greenwood discusses the impact of the financial meltdown on biotech companies. The demand for biotech products that save lives and address global needs will remain strong, he says, despite the current economic squeeze. Download or listen to the program.